AR016196A1 - Suspension de principio activo peroral - Google Patents
Suspension de principio activo peroralInfo
- Publication number
- AR016196A1 AR016196A1 ARP990101338A ARP990101338A AR016196A1 AR 016196 A1 AR016196 A1 AR 016196A1 AR P990101338 A ARP990101338 A AR P990101338A AR P990101338 A ARP990101338 A AR P990101338A AR 016196 A1 AR016196 A1 AR 016196A1
- Authority
- AR
- Argentina
- Prior art keywords
- dispersion medium
- suspension
- less
- microm
- particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una suspension, aplicable por vía oral, de un principio activo farmacéutico del tipo FNEAI con un espectro del tamano de granos suspendible en un medio dedispersion fisiologicamente indiferente, en la que la solubilidad del principio activo es muyes casa, preferiblemente menor que 500 microg/ml, de modo que lasuspension no presenta ningun sabor específico perceptible, suspension que contiene una pequena cantidad de dioxido de silicio muy disperso para laestabilizacion mediante formacion deuna e structura siloide tridimensional, creándose la estructura siloide tridimensional mediante la incorporacion deldioxido de silicio en el medio de dispersion bajo la accion de elevadas fuerzas de cizallamiento, y que contiene adicionalmente unapequena cantidad depolímeros hidrofilos solubles en el medio de dispersion. Un procedimiento para la produccion de un preparado líquido, aplicable p.o., de un principio activofarmacéutico del tipo FNEAI en forma de una suspension estabilizada,procedimiento en el cual: (i) se muele el principio activo solido, de modo que se crea unespectro del tamano de granos en el que al menos el 90% de las partículas es menor que 50 microm, pero preferiblemente al menos el 50% de las partículas esmenorque 10 microm, pero en particular, aproximadamente el 90% de las partículas es menor que 10 microm; (ii) el principio activo molido se suspende en unmedio de dispersion fisiologicamente indiferente en el que la solubilidad del principio activo esmuy escasa; (iii) en el medio de dispersion se incorporan,con empleo de elevadas fuerzas de cizallamiento, pequenas cantidades de dioxido de silicio muy disperso; (iv) al medio de dispersion se anaden pequenascantidades de polímeros hidrofilossolubles en el medio de dispersion y (v) al medio de dispersion se pueden anadir, opcionalmente independientes una de otra,una o varias sustancias aromáticas, uno o varios edulcorantes, coadyuvantes ususales o uno o varios agentes conservantes,efectuándose la adicion de l assustancias aromáticas en virtud de sus propiedades disgregantes de la espuma preferiblemente en la ultima etapa de la preparacion. La utilizacion de un
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98105568A EP0945131A1 (de) | 1998-03-27 | 1998-03-27 | Perorale Wirkstoff-Suspension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR016196A1 true AR016196A1 (es) | 2001-06-20 |
Family
ID=8231651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101338A AR016196A1 (es) | 1998-03-27 | 1999-03-26 | Suspension de principio activo peroral |
Country Status (25)
| Country | Link |
|---|---|
| EP (2) | EP0945131A1 (es) |
| JP (1) | JP3323189B2 (es) |
| KR (1) | KR100587208B1 (es) |
| CN (1) | CN1150888C (es) |
| AR (1) | AR016196A1 (es) |
| AT (1) | ATE225648T1 (es) |
| AU (1) | AU762464B2 (es) |
| BR (1) | BR9909189A (es) |
| CA (1) | CA2326048C (es) |
| CO (1) | CO5070601A1 (es) |
| DE (1) | DE59903023D1 (es) |
| DK (1) | DK1066029T3 (es) |
| ES (1) | ES2184428T3 (es) |
| HU (1) | HU228474B1 (es) |
| IL (1) | IL137479A (es) |
| MY (1) | MY124599A (es) |
| NO (1) | NO321401B1 (es) |
| NZ (1) | NZ507610A (es) |
| PL (1) | PL192969B1 (es) |
| PT (1) | PT1066029E (es) |
| TR (1) | TR200002772T2 (es) |
| TW (1) | TWI232759B (es) |
| UY (1) | UY25443A1 (es) |
| WO (1) | WO1999049845A1 (es) |
| ZA (1) | ZA200003951B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8231899B2 (en) | 1998-09-10 | 2012-07-31 | Nycomed Danmark Aps | Quick release pharmaceutical compositions of drug substances |
| US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
| DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
| US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
| EP1938803A3 (en) * | 2003-03-03 | 2010-10-27 | Elan Pharma International Limited | Formulations comprising nanoparticulate meloxican |
| US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
| US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
| CA2521603A1 (en) * | 2003-04-07 | 2004-10-21 | Jurox Pty Ltd | Stable carprofen composition |
| US20050158367A1 (en) * | 2004-01-16 | 2005-07-21 | The Procter & Gamble Company | Liquid compositions comprising one or more medicaments |
| EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
| WO2006042381A1 (en) * | 2004-10-21 | 2006-04-27 | Parnell Laboratories (Aust) Pty Limited | Anti-inflammatory preparation |
| EP1824493B1 (en) * | 2004-12-06 | 2008-08-13 | Janssen Pharmaceutica N.V. | Oral suspension comprising meloxicam |
| GB2438287A (en) * | 2006-05-19 | 2007-11-21 | Norbrook Lab Ltd | Stable aqueous suspension |
| ES3037313T3 (en) | 2009-10-12 | 2025-09-30 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
| MX2012010077A (es) | 2010-03-03 | 2012-09-12 | Boehringer Ingelheim Vetmed | Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos. |
| US20110218191A1 (en) * | 2010-03-03 | 2011-09-08 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long term-treatment of kidney disorders in cats |
| CA2800235C (en) * | 2010-03-10 | 2018-10-16 | Lupin Limited | Rifaximin ready-to-use suspension |
| HUE066482T2 (hu) * | 2010-03-19 | 2024-08-28 | 1Globe Biomedical Co Ltd | Új eljárások rákõssejtek megcélzására |
| US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
| GB201117858D0 (en) | 2011-10-17 | 2011-11-30 | Norbrook Lab Ltd | Paste |
| EP2937640A4 (en) * | 2012-12-19 | 2016-08-17 | Mitsubishi Electric Corp | AIR CONDITIONING |
| US11388914B2 (en) | 2015-04-28 | 2022-07-19 | Mars, Incorporated | Process of preparing a wet pet food, wet pet food produced by the process and uses thereof |
| KR102145022B1 (ko) * | 2018-08-14 | 2020-08-14 | 동아제약 주식회사 | 이부프로펜의 현탁액 조성물 및 투여 제형 |
| CN112044605B (zh) * | 2019-06-06 | 2022-06-21 | 钟志勇 | 选钛药剂及选钛方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196307B (it) * | 1984-10-22 | 1988-11-16 | Chiesi Farma Spa | Formulazioni farmaceutiche acquose di piroxicam monoidrato |
| US4835187A (en) * | 1987-06-15 | 1989-05-30 | American Home Products Corporation | Spray dried ibuprofen |
| JP2860729B2 (ja) * | 1992-03-10 | 1999-02-24 | エスエス製薬株式会社 | プラノプロフェン懸濁シロップ剤 |
| GB2318511A (en) * | 1996-10-23 | 1998-04-29 | Eurand Int | Process for the preparation of a pharmaceutical composition for rapid suspension in water |
-
1998
- 1998-03-27 EP EP98105568A patent/EP0945131A1/de not_active Withdrawn
-
1999
- 1999-03-04 TW TW088103315A patent/TWI232759B/zh not_active IP Right Cessation
- 1999-03-23 PL PL342345A patent/PL192969B1/pl unknown
- 1999-03-23 NZ NZ507610A patent/NZ507610A/en not_active IP Right Cessation
- 1999-03-23 DE DE59903023T patent/DE59903023D1/de not_active Expired - Lifetime
- 1999-03-23 CN CNB998044695A patent/CN1150888C/zh not_active Expired - Lifetime
- 1999-03-23 PT PT99913291T patent/PT1066029E/pt unknown
- 1999-03-23 EP EP99913291A patent/EP1066029B1/de not_active Expired - Lifetime
- 1999-03-23 AT AT99913291T patent/ATE225648T1/de active
- 1999-03-23 IL IL13747999A patent/IL137479A/xx not_active IP Right Cessation
- 1999-03-23 CA CA002326048A patent/CA2326048C/en not_active Expired - Lifetime
- 1999-03-23 HU HU0102036A patent/HU228474B1/hu unknown
- 1999-03-23 DK DK99913291T patent/DK1066029T3/da active
- 1999-03-23 ES ES99913291T patent/ES2184428T3/es not_active Expired - Lifetime
- 1999-03-23 WO PCT/EP1999/001948 patent/WO1999049845A1/de not_active Ceased
- 1999-03-23 KR KR1020007010684A patent/KR100587208B1/ko not_active Expired - Lifetime
- 1999-03-23 TR TR2000/02772T patent/TR200002772T2/xx unknown
- 1999-03-23 AU AU31470/99A patent/AU762464B2/en not_active Expired
- 1999-03-23 JP JP2000540811A patent/JP3323189B2/ja not_active Expired - Lifetime
- 1999-03-23 BR BR9909189-5A patent/BR9909189A/pt not_active Application Discontinuation
- 1999-03-24 UY UY25443A patent/UY25443A1/es not_active IP Right Cessation
- 1999-03-25 MY MYPI99001139A patent/MY124599A/en unknown
- 1999-03-26 CO CO99018550A patent/CO5070601A1/es unknown
- 1999-03-26 AR ARP990101338A patent/AR016196A1/es not_active Application Discontinuation
-
2000
- 2000-08-03 ZA ZA200003951A patent/ZA200003951B/xx unknown
- 2000-09-26 NO NO20004822A patent/NO321401B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR016196A1 (es) | Suspension de principio activo peroral | |
| ES2176206T5 (es) | Derivados de ciclodextrinas que muestran solubilidad incrementada en el agua y utilizacion de los mismos. | |
| JP6282644B2 (ja) | ラセカドトリル液体組成物 | |
| PT90171B (pt) | Processo para a preparacao de uma composicao contendo timol cujo sabor esta dissimulado | |
| JP6799126B2 (ja) | 口腔ケア組成物 | |
| ITFI970184A1 (it) | Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico | |
| CN107613956A (zh) | 口腔用组合物、食品或饮料 | |
| WO2018235147A1 (ja) | タブレット型凍結乾燥化粧料 | |
| Sharma et al. | Liquisolid system of paclitaxel using modified polysaccharides: In vitro cytotoxicity, apoptosis study, cell cycle analysis, in vitro mitochondrial membrane potential assessment, and pharmacokinetics | |
| CA1249223A (en) | Solid drug formulations and stable suspensions | |
| EP3165218A1 (en) | Water dispersible granulates containing oxidized or reduced forms of coenzyme q10 | |
| TW201726100A (zh) | 錠型凍結乾燥化妝料 | |
| KR20180114881A (ko) | 일회용 경량 동결건조 화장품 | |
| CN111093620A (zh) | 用于预防毛发脱落或促进毛发生长的组合物 | |
| KR20160096199A (ko) | 라세카도트릴 액체 조성물 | |
| KR101595107B1 (ko) | 플라보이드 분획 및 잔탄 검을 포함하는 경구 현탁액 형태의 약학 조성물 | |
| JP2009149622A (ja) | 皮膚用乳化化粧料 | |
| JPH11279042A (ja) | 皮膚外用剤 | |
| KR102281492B1 (ko) | 세벨라머 함유 경구투여용 현탁제 조성물 및 그 제조방법 | |
| Kalava et al. | Physicochemical characterization and dissolution properties of cinnarizine solid dispersions | |
| KR20150121409A (ko) | 아스코빅애씨드 2-글루코사이드를 안정화시키는 방법 및 안정화된 아스코빅애씨드 2-글루코사이드를 함유하는 화장료 조성물 | |
| JP2009084278A (ja) | 口腔用組成物 | |
| TWI865713B (zh) | 含有Ｔｒｅｈａｎｇｅｌｉｎ的皮膚洗淨劑及片層形成促進劑 | |
| JP7796486B2 (ja) | 味覚改善剤 | |
| KR101191919B1 (ko) | 쪽 초임계 추출물을 유효성분으로 함유하는 치약 조성물 및 이의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |